Biotech's Reinvented Future: Key Investments and Trials
Kilder
- Nature: Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue - Nature
- Nature: Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial | Nature Medicine - Nature
- Statnews: Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound - statnews.com
- Statnews: Is biotech back? Don’t jinx it, but the signs are encouraging - statnews.com
- Fiercebiotech: Enveda harvests another $150M to advance nature-inspired drugs - Fierce Biotech
- Bioworld: Sanofi’s amlitelimab hits phase III endpoints in atopic dermatitis - BioWorld MedTech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.